Literature DB >> 6816585

Opsonization and phagocytosis of mucoid and non-mucoid Pseudomonas aeruginosa strains.

T Meshulam, H A Verbrugh, J Verhoef.   

Abstract

The interaction between Pseudomonas aeruginosa strains (6 non-mucoid and 4 mucoid strains), serum factors and phagocytic cells was investigated. Strains were incubated in different concentrations of normal serum, chelated serum (with only the alternative complement pathway intact), IgG, Cls, C2 and C3 deficient serum and immune serum. After incubation complement consumption, C3 fixation and phagocytosis by polymorphonuclear leukocytes (PMN) were measured. In contrast to normal serum, immune serum raised against a mucoid and a non-mucoid strain exhibited heat-stable opsonic activity. All ten Pseudomonas aeruginosa strains were able to activate complement in 20% normal serum, leading to deposition of the activated form of the third complement component on the bacterial cell wall and to subsequent recognition and phagocytosis. One mucoid and four non-mucoid strains activated the alternative complement pathway and were effectively opsonized in chelated or in Cls, C2 or IgG deficient serum. Although mucoid strains were less able to activate complement via the alternative route, no differences were observed in opsonic requirements and phagocytosis between mucoid and non-mucoid strains.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6816585     DOI: 10.1007/bf02014202

Source DB:  PubMed          Journal:  Eur J Clin Microbiol        ISSN: 0722-2211            Impact factor:   3.267


  15 in total

1.  A more sensitive plate assay for detection of protease production by Pseudomanas aeruginosa.

Authors:  P A Sokol; D E Ohman; B H Iglewski
Journal:  J Clin Microbiol       Date:  1979-04       Impact factor: 5.948

2.  [Research on O-antigens of Pseudomonas aeruginosa].

Authors:  I HABS
Journal:  Z Hyg Infektionskr       Date:  1957

3.  Activation of the alternative complement pathway by pneumococcal cell wall teichoic acid.

Authors:  J A Winkelstein; A Tomasz
Journal:  J Immunol       Date:  1978-01       Impact factor: 5.422

4.  Pseudomonas bacteremia in patients with malignant diseases.

Authors:  J P Whitecar; M Luna; G P Bodey
Journal:  Am J Med Sci       Date:  1970-10       Impact factor: 2.378

5.  Kinetics of staphylococcal opsonization, attachment, ingestion and killing by human polymorphonuclear leukocytes: a quantitative assay using [3H]thymidine labeled bacteria.

Authors:  J Verhoef; P K Peterson; P G Quie
Journal:  J Immunol Methods       Date:  1977       Impact factor: 2.303

6.  The slime of Pseudomonas aeruginosa: biological characterization and possible role in experimental infection.

Authors:  J W Sensakovic; P F Bartell
Journal:  J Infect Dis       Date:  1974-02       Impact factor: 5.226

7.  Bacteremia due to Pseudomonas aeruginosa complicating neoplastic disease: a progress report.

Authors:  M L Tapper; D Armstrong
Journal:  J Infect Dis       Date:  1974-11       Impact factor: 5.226

8.  Staphylococcus aureus opsonization mediated via the classical and alternative complement pathways. A kinetic study using MgEGTA chelated serum and human sera deficient in IgG and complement factors C1s and C2.

Authors:  H A Verbrugh; W C Van Dijk; R Peters; M E Van Der Tol; P K Peterson; J Verhoef
Journal:  Immunology       Date:  1979-03       Impact factor: 7.397

9.  Lipopolysaccharide pseudomonas vaccine: efficacy against pulmonary infection with Pseudomonas aeruginosa.

Authors:  J E Pennington
Journal:  J Infect Dis       Date:  1979-07       Impact factor: 5.226

10.  Pseudomonas aeruginosa infection in cystic fibrosis. Bactericidal effect of serum from normal individuals and patients with cystic fibrosis on P. aeruginosa strains from patients with cystic fibrosis or other diseases.

Authors:  N Holby; S Olling
Journal:  Acta Pathol Microbiol Scand C       Date:  1977-04
View more
  5 in total

Review 1.  Adaptation of Pseudomonas aeruginosa to the cystic fibrosis airway: an evolutionary perspective.

Authors:  Anders Folkesson; Lars Jelsbak; Lei Yang; Helle Krogh Johansen; Oana Ciofu; Niels Høiby; Søren Molin
Journal:  Nat Rev Microbiol       Date:  2012-11-13       Impact factor: 60.633

Review 2.  Alginate synthesis by Pseudomonas aeruginosa: a key pathogenic factor in chronic pulmonary infections of cystic fibrosis patients.

Authors:  T B May; D Shinabarger; R Maharaj; J Kato; L Chu; J D DeVault; S Roychoudhury; N A Zielinski; A Berry; R K Rothmel
Journal:  Clin Microbiol Rev       Date:  1991-04       Impact factor: 26.132

3.  Role of lipopolysaccharide in opsonization and phagocytosis of Pseudomonas aeruginosa.

Authors:  W Engels; J Endert; M A Kamps; C P van Boven
Journal:  Infect Immun       Date:  1985-07       Impact factor: 3.441

4.  Resistance of mucoid Pseudomonas aeruginosa to nonopsonic phagocytosis by alveolar macrophages in vitro.

Authors:  D P Krieg; R J Helmke; V F German; J A Mangos
Journal:  Infect Immun       Date:  1988-12       Impact factor: 3.441

5.  Age-related variations in the in vitro bactericidal activity of human sera against Pseudomonas aeruginosa.

Authors:  Akram Khan; Isfahan Tauseef; Bibi Aalia; Muhammad Azam Khan; Sadia Akbar; Nighat Sultana; Kashif S Haleem
Journal:  Cent Eur J Immunol       Date:  2018-03-30       Impact factor: 2.085

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.